ACTSI Investigator Dr. Guillermo Umpierrez in the News

Guillermo Umpierrez, MD, ACTSI investigator, ACTSI Grady Clinical Research Site director, and professor of medicine at Emory University

Reuters | | | Lilly once-weekly diabetes drug proves superior in late-stage trials
June 22, 2013

Emory Report | Honors for Davies, Eckert, Thomas, & Umpierrez
June 27, 2013

Recent Publications: Prevalence, Quality of Care, and Complications in Long Term Care Residents With Diabetes: A Multicenter Observational Study | Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized, controlled study | Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? Insulin therapy has proven itself and is considered the mainstay of treatment